[Pharmaceutical interventions in the new medicine service].

IF 0.6 Q4 HEALTH POLICY & SERVICES
Farmaceuticos Comunitarios Pub Date : 2025-05-19 eCollection Date: 2025-07-15 DOI:10.33620/FC.2173-9218.(2025).17
D Barris Blundell, G Benítez Pacheco, M J Hidalgo Hidalgo, M A Mercado Cano
{"title":"[Pharmaceutical interventions in the new medicine service].","authors":"D Barris Blundell, G Benítez Pacheco, M J Hidalgo Hidalgo, M A Mercado Cano","doi":"10.33620/FC.2173-9218.(2025).17","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>A study is presented whose main objective is to describe pharmaceutical interventions in the assistance service in the dispensing of newly prescribed medications in patients of two community pharmacies.</p><p><strong>Methodology: </strong>Descriptive observational study, carried out in two community pharmacies in the province of Malaga with patients who come for new medical prescriptions over 6 months (March 2022 - August 2022). Pharmaceutical interventions have been recorded, recording the following aspects: age, sex, new prescription, other medications, pharmaceutical intervention (posology-dose, indication), follow-up of the new medication. Regarding the follow-up of the new medication, the detection of a drug-related Problem (DRP) (possible adverse effects, interactions, lack adherence) and/or a Negative Outcome associated with Medication (NOM) has been recorded in the Dáder method intervention sheet.</p><p><strong>Results: </strong>251 records of new medication have been documented, which have totalled 258 new prescription medications. The average age of the patients was 58.6 years. The average number of medications used by the patients was 5.1 with a range between 1 and 15. In relation to the sex of the patients, 41.4% (n=104) were men and 58.6% (n=147) were women.The five therapeutic groups most studied have been: C10 Lipid-modifying agents (n=33), A10 Drugs used in diabetes (n=28), C09 Agents that act on the renin-angiotensin system (n=21), N06 Psychoanaleptics (n=19) and M01 Anti-inflammatory and antirheumatic products (n=13).A NOM was detected in 31.5% (n=79) of the patients, with non-quantitative safety problem being the most frequent (60.0% - n=48). 23 DRP of lack adherence have been documented.</p><p><strong>Conclusions: </strong>The development of this service represents an opportunity for the team's assistant pharmacists to participate in a Clinical Professional Pharmacy Services in a homogeneous and systematized way, with the consequent documentation of their interventions and with a more active involvement in the patients' health processes. The need for greater integration of the two community pharmacies in the health system is evident.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 3","pages":"17-25"},"PeriodicalIF":0.6000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12282467/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmaceuticos Comunitarios","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33620/FC.2173-9218.(2025).17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/15 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: A study is presented whose main objective is to describe pharmaceutical interventions in the assistance service in the dispensing of newly prescribed medications in patients of two community pharmacies.

Methodology: Descriptive observational study, carried out in two community pharmacies in the province of Malaga with patients who come for new medical prescriptions over 6 months (March 2022 - August 2022). Pharmaceutical interventions have been recorded, recording the following aspects: age, sex, new prescription, other medications, pharmaceutical intervention (posology-dose, indication), follow-up of the new medication. Regarding the follow-up of the new medication, the detection of a drug-related Problem (DRP) (possible adverse effects, interactions, lack adherence) and/or a Negative Outcome associated with Medication (NOM) has been recorded in the Dáder method intervention sheet.

Results: 251 records of new medication have been documented, which have totalled 258 new prescription medications. The average age of the patients was 58.6 years. The average number of medications used by the patients was 5.1 with a range between 1 and 15. In relation to the sex of the patients, 41.4% (n=104) were men and 58.6% (n=147) were women.The five therapeutic groups most studied have been: C10 Lipid-modifying agents (n=33), A10 Drugs used in diabetes (n=28), C09 Agents that act on the renin-angiotensin system (n=21), N06 Psychoanaleptics (n=19) and M01 Anti-inflammatory and antirheumatic products (n=13).A NOM was detected in 31.5% (n=79) of the patients, with non-quantitative safety problem being the most frequent (60.0% - n=48). 23 DRP of lack adherence have been documented.

Conclusions: The development of this service represents an opportunity for the team's assistant pharmacists to participate in a Clinical Professional Pharmacy Services in a homogeneous and systematized way, with the consequent documentation of their interventions and with a more active involvement in the patients' health processes. The need for greater integration of the two community pharmacies in the health system is evident.

[新药服务中的药物干预]。
目的:提出了一项研究,其主要目的是描述药物干预援助服务在配药新处方的两个社区药房的病人。方法:描述性观察研究,在马拉加省的两家社区药房进行,患者在6个月内(2022年3月至2022年8月)来接受新的医疗处方。药物干预记录,记录以下方面:年龄,性别,新处方,其他药物,药物干预(生理剂量,适应证),新药随访。关于新药物的随访,药物相关问题(DRP)(可能的不良反应、相互作用、缺乏依从性)和/或药物相关负面结果(NOM)的检测已记录在Dáder方法干预表中。结果:共记录新用药251例,其中新处方药258例。患者平均年龄58.6岁。患者平均使用药物5.1种,范围在1 ~ 15种之间。从患者的性别来看,41.4% (n=104)为男性,58.6% (n=147)为女性。研究最多的五个治疗组是:C10脂质调节剂(n=33), A10用于糖尿病的药物(n=28), C09作用于肾素-血管紧张素系统的药物(n=21), N06精神镇痛药(n=19)和M01抗炎和抗风湿产品(n=13)。在31.5% (n=79)的患者中检测到NOM,其中非定量安全性问题最为常见(60.0% - n=48)。已记录了缺乏依从性的DRP。结论:这项服务的发展代表了团队助理药剂师以同质和系统化的方式参与临床专业药房服务的机会,从而记录了他们的干预措施,并更积极地参与了患者的健康过程。显然,需要在卫生系统中进一步整合这两个社区药房。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Farmaceuticos Comunitarios
Farmaceuticos Comunitarios HEALTH POLICY & SERVICES-
CiteScore
0.40
自引率
33.30%
发文量
351
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信